A carregar...
Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerations
Multiple sclerosis (MS) is among the most common chronic inflammatory diseases of the central nervous system. Although not curable, the constantly increasing armamentarium of disease-modifying drugs now allows control of disease activity in many patients. The humanized monoclonal antibody alemtuzuma...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5076850/ https://ncbi.nlm.nih.gov/pubmed/27799738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S97956 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|